CMI vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CMI

43.2
AI Score
VS
EMR Wins

EMR

47.5
AI Score

Investment Advisor Scores

CMI

43score
Recommendation
HOLD

EMR

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMI EMR Winner
Forward P/E 20 21.8818 CMI
PEG Ratio 1.3749 1.8165 CMI
Revenue Growth 9.4% 7.0% CMI
Earnings Growth 4.7% 23.0% EMR
Tradestie Score 43.2/100 47.5/100 EMR
Profit Margin 7.8% 13.8% EMR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CMI 1M: -11.6% · 3M: -8.0% EMR 1M: +8.5% · 3M: +16.6%

Current Technical Phase

CMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $587.68

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 55

RSI (14): 55.0 · Price: $157.26

Fundamentals Snapshot

Metric CMI EMR
Market Cap
Forward P/E 17.3 21.7
Trailing P/E 31.1 34.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.3%
EPS 19.10 4.49
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.